Ibere Pharmaceuticals
Status: Liquidated
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $138.00M |
|---|---|
| IPO Date | Feb 26, 2021 |
| CEO | Osagie Imasogie |
| Left Lead | Raymond James |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | N/A |
| Deal Announced | N/A |
| Deal Size, $M | TBD |
| Deal Sector | TBD |
| Deal Geography | TBD |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | TBD |
| Amendment Vote | TBD |
| Closing Date | Mar 2, 2023 |
IBER
IBER.U
IBER/W
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.